Clinical Trials Logo

Type 2 Diabetes clinical trials

View clinical trials related to Type 2 Diabetes.

Filter by:

NCT ID: NCT04945109 Completed - Type 2 Diabetes Clinical Trials

Wolffia Globosa (Mankai) and Glycemic Control Among Patients With Type 2 Diabetes

Start date: October 19, 2021
Phase: N/A
Study type: Interventional

The investigators primarily aim to explore the effect of daily additive supplementation of Mankai on glucose control among participants with T2D.

NCT ID: NCT04943692 Suspended - Type 2 Diabetes Clinical Trials

Efficacy and Safety of Metformin Glycinate Compared to Metformin Hydrochloride on the Progression of Type 2 Diabetes

COMETII
Start date: August 2021
Phase: Phase 3
Study type: Interventional

Phase III study to evaluate the efficacy and safety of the treatment. Two-arm, prospective, longitudinal, double-blind, multicenter randomized clinical trial.

NCT ID: NCT04941794 Recruiting - Type 2 Diabetes Clinical Trials

Biomarkers as Predictors of Chronic Heart Failure in Patients With Type 2 Diabetes

Start date: July 1, 2021
Phase:
Study type: Observational

A cohort study on patients with type 2 diabetes to investigate possible biomarkers as predictors of chronic heart failure.

NCT ID: NCT04931836 Completed - Obesity Clinical Trials

The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults

Start date: July 29, 2021
Phase: N/A
Study type: Interventional

The present study is a 100-participant randomized controlled 2-arm parallel trial that employs a metagenomic approach to examine how 8 weeks of supervised moderate-intensity treadmill walking exercise (MWE) for 30-45 min 3 times/week alters the gut microbiome, serum short chain fatty acids, and the cardiometabolic profile, body weight, and body composition of individuals 30-64 years old who have overweight or obesity and have prediabetes.

NCT ID: NCT04924400 Not yet recruiting - Type 2 Diabetes Clinical Trials

Complete Health Improvement Program for Geisinger Health Plan Members With Type 2 Diabetes

CHIP-RCT
Start date: March 2022
Phase: N/A
Study type: Interventional

The Complete Health Improvement Program (CHIP) is a lifestyle improvement program intended to prevent and/or manage cardiovascular disease, diabetes, and other health conditions. This is a pilot-scale randomized-controlled trial comparing the clinical, utilization, and financial outcomes of adult health plan members with type 2 diabetes mellitus (T2DM) offered CHIP versus those only offered standard health plan coverage. We hypothesize that Geisinger Health Plan (GHP) members with T2DM offered CHIP in addition to standard insurance coverage will have improvement in HbA1c and improvements in other biometrics, biomarkers, psychometrics and utilization/financial outcomes, including LDL-C, systolic blood pressure, body mass index, waist circumference, number of diabetes medications prescribed, Wellbeing360 survey, and total cost of healthcare.

NCT ID: NCT04921306 Completed - Type 2 Diabetes Clinical Trials

Obese Human Beta-2-adrenergic Stimulation and Muscle Glucose Uptake

Start date: August 16, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to investigate the effect of four weeks clenbuterol/placebo supplementation on skeletal muscle glucose disposal in overweight/obese male and (postmenopausal) female volunteers.

NCT ID: NCT04917471 Recruiting - Type 2 Diabetes Clinical Trials

Effect of Nitrate on Red Blood Cell Function in Type 2 Diabetes

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

To investigate the effect of nitrate supplementation on red blood cell function in patients with type 2 diabetes.

NCT ID: NCT04917393 Recruiting - Hypertension Clinical Trials

Multi-Organ Denervation With the iRF System to RedUce Sympathetic Drive

MODUS
Start date: September 13, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the safety of multi-organ denervation using the Integrated Radio Frequency (iRF) Denervation System. and to understand any potential improvement in hypertension and glycemic control.

NCT ID: NCT04910997 Withdrawn - Clinical trials for Diabetes Mellitus, Type 2

Heart Rate Variability-Guided Exercise Training in Type 2 Diabetes

Start date: June 1, 2021
Phase: N/A
Study type: Interventional

The primary aim of this randomized clinical trial is to determine the effectiveness of a 16 wk individualized aerobic exercise program, using heart rate variability to guide the exercise prescription, for increasing aerobic capacity of individuals with type 2 diabetes, compared to a traditional exercise training paradigm and usual care. To accomplish this aim the investigators plan to test for greater improvements in: 1) fitness (primary outcome); as well as secondary variables of 2) cardiovascular autonomic function via baroreflex function; 3) glucose control (HbA1c); and 4) psychosocial factors.

NCT ID: NCT04907110 Completed - Type 2 Diabetes Clinical Trials

NR Supplementation and Exercise

Start date: August 10, 2021
Phase: N/A
Study type: Interventional

The number of age-related chronic diseases (like obesity, type 2 diabetes and cardiovascular diseases) is increasing rapidly worldwide, reaching pandemic proportions. These age-related chronic diseases are associated with metabolic disturbances and mitochondrial dysfunction in humans. Nicotinamide adenosine dinucleotide (NAD) levels play an important role in energy metabolism and mitochondrial functioning and indeed it has been shown that high concentrations of NAD+ as well as a high NAD+/NADH ratio are strongly associated with metabolic and mitochondrial health. In contrast, decreased NAD+ bioavailability is reported in both ageing and obese humans as well as in diabetic mice. These findings fueled the idea of influencing NAD+ bioavailability in order to improve metabolic disturbances and mitochondrial dysfunction in humans. Supplementation with nicotinamide riboside (NR), a naturally occurring form of vitamin B3, may provide a way to boost cellular NAD+ levels. However, in contrast to animal studies, NR supplementation in humans has so far been unsuccessful in improving skeletal muscle mitochondrial function, exercise capacity or insulin sensitivity. Recently, it has been suggested that a situation where NAD+ levels become limited, is needed for NR supplementation to exert beneficial health effects. This situation could be achieved by combining exercise and NR supplementation. However, studies combining NR and exercise are lacking, which is why we would like to perform such a study here.